|
1) 日本透析医学会統計調査委員会. わが国の慢性透析療法の現況. 透析会誌. 2011; 44: 1-36
|
|
|
|
|
2) Goodkin DA, Bragg-Gresham JL, Koening KG, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States in the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003; 14: 3270-7
|
|
|
|
|
3) 日本臨床腎移植学会. 腎移植臨床登録集計報告(2010)-2. 2009年実施症例の集計報告(2). 移植. 2010; 45: 595-620
|
|
|
|
|
4) 剣持 敬, 西郷健一, 丸山通広, 他. 長期透析患者の腎移植の適応とその問題点. 腎と透析. 2008; 65: 363-7
|
|
|
|
|
|
5) 野本亀久雄, 他編. 日本臓器移植ネットワーク. 2007臓器提供移植データブック. 東京: 社団法人日本臓器移植ネットワーク; 2008
|
|
|
|
|
|
6) 秋澤忠男. 序: 透析療法の課題と透析液清浄化. 医薬ジャーナル. 2009; 45: 77-9
|
|
|
|
|
|
7) 新田孝作. 長期透析症候群: 定義と概念. 腎と透析. 2010; 69: 541-4
|
|
|
|
|
|
8) Shirali AC, Bia MJ. Management of cardiovascular disease in renal transplant recipients. Clin J Am Soc Nephrol. 2008; 3: 491-504
|
|
|
|
|
|
9) Charytan D, Kuntz RE, Mauri L, et al. Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients. Am J Kidney Dis. 2007; 49: 409-16
|
|
|
|
|
|
10) Abbott KC, Yuan CM, Tayler Aj, et al. Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression. J Am Soc Nephrol. 2003; 14: 2358-65
|
|
|
|
|
|
11) Meier-Krieshe HU, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after transplantation. Transplantation. 2003; 75: 1291-5
|
|
|
|
|
|
12) Fellstrom B, Jardine AG, Soveri I, et al. Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation. Am J Transplant. 2005; 5: 1986-91
|
|
|
|
|
|
13) Liefeldt L, Buddle K. Risk factors for cardiovasucular disease in renal transplant recipients and strategies to minimize risk. Transpl Int. 2010; 12: 1191-204
|
|
|
|
|
|
14) Toyoda K, Fujii K, Fujimi S, et al. Stroke in patients on maintenance hemodialysis: a 22-year single center study. Am J Kidney Dis. 2005; 45: 1058-66
|
|
|
|
|
|
15) Fukuda N, Tanaka H, Tominaga Y, et al. Decreased 1, 25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest. 1993; 92: 1436-43
|
|
|
|
|
|
16) Gwinner W, Suppa S, Mengel M, et al. Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications. Am J Transplant. 2005; 5: 1934-41
|
|
|
|
|
|
17) Dunnill MS, Millard PR, Oliver D. Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J Clin Path. 1977; 30: 868-77
|
|
|
|
|
|
18) 瀬戸口志保, 中澤速和, 伊藤文夫, 他. 透析期間20年以上の長期患者における腎癌の臨床病理学的検討. 透析会誌. 2007; 40: 643-7
|
|
|
|
|
|
19) Martins PN, Pratschke J, Pascher A, et al. Age and immune response in organ transplantation. Transplantation. 2005; 79: 127-32
|
|
|
|
|
|
20) Trouillhet I, Benito N, Cervera C, et al. Influence of age in renal transplant infections : case and controls study. Transplantation. 2005; 80: 989-92
|
|
|
|
|
|
21) Matsuoka M, Iseki K, Tamachiro M, et al. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol. 2004; 8: 54-8
|
|
|
|
|
|
22) Okuno S, Ishimura E, Kitatani K, et al. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortaliry in maintenance hemodialysis patients. Am J Kidney Dis. 2007; 49: 417-25
|
|
|
|
|
|
23) Kawanishi H, Kawaguchi Y, Fukui H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis. 2004; 44: 729-37
|
|
|
|
|
|
24) Fabrizii V, Winkelmayer WC, Klauser R, et al. Patient and graft survival in older kidney transplant recipients: does age matter？ J Am Soc Nephrol. 2004; 15: 1052-60
|
|
|
|
|
|
25) 日本透析医学会. 透析患者のC型ウイルス肝炎治療ガイドライン. 日本透析医学会雑誌. 2011; 44: 481-531
|
|
|
|
|
26) Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, et al. Duration of end-stage renal disease and kidney transplant outcome. Nephrol Dial Transplant. 2005; 20: 167-75
|
|
|
|
|
|
27) Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation. 2002; 74: 1377-981
|
|
|
|
|
|
28) Mange KC, Joffe MM, Feldman HI. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med. 2001; 344: 726-31
|
|
|
|
|
|
29) Ushigome H, Sakai K, Suzuki T, et al. Kidney transplantation for patients on long-term hemodialysis. Transplant Proc. 2008; 40: 2297-8
|
|
|
|
|
|
30) Bittar J, Arenas P, Chiurchiu C, et al. Renal transplantation in high cardiovascular risk patients. Transplant Rev. 2009; 23: 224-34
|
|
|
|
|
|
31) Kasiske BL, Israni AK, Snyder JJ, et al. A simple tool to predict outcomes after kidney transplant. Am J Kidney Dis. 2010; 56: 947-60
|
|
|
|
|
|
32) Geddes CC, Woo TM, Jardine AG. The impact of delayed graft function on the long-term outcome of renal transplantation. J Nephrol. 2002; 15: 17-21
|
|
|
|
|
|
33) Yarlagadda SG, Coca SG, Formica RN, et al. Association between delayed graft function and allograt and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant. 2009; 24: 1039-47
|
|
|
|
|
|
34) Tapiawala SN, Tinckam KJ, Cardella CJ, et al. Delayed graft function and the risk for death with a functioning graft. J Am Soc Nephrol. 2010; 21: 153-61
|
|
|
|
|
|
35) Narayanan R, Cardella CJ, Cattran DC, et al. Delayed graft function and risk of death with graft function in living donor kidney transplant recipients. Am J Kidney Dis. 2010; 56: 961-70
|
|
|
|
|
|
36) DeLoach SS, Joffe MM, Mai X, et al. Aortic calcification predicts cardiovascular events and all-cause mortality in renal transplantation. Nephrol Dial Transplant. 2009; 24: 1314-9
|
|
|
|
|
|
37) Zhang Q, Liang LW, Gjertson DW, et al. Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction. Transplantation. 2005; 79: 591-8
|
|
|
|
|
|
38) Gloor J, Stegall MD. Sensitized renal transplant recipients: current protocols and future directions. Nat Rev Nephrol. 2010; 6: 297-306
|
|
|
|
|
|
39) Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999; 341: 1725-30
|
|
|
|
|
|
40) Rabbat CG, Thorpe KE, Russell JD, et al. Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. J Am Soc Nephrol. 2000; 11: 917-22
|
|
|
|
|
|
41) Meier-Kriesche HU, Ojo AO, Port FK, et al. Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol. 2001; 12: 1293-6
|
|
|
|
|
|
42) Oniscu GC, Brown H, Forsythe JL, et al. Impact of cadaveric renal transplantation on survival on patients listed for transplantation. J Am Soc Nephrol. 2005; 16: 1859-65
|
|
|
|
|
|
43) Gill JS, Tonelli M, Johnson N, et al. The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation. Kidney Int. 2005; 68: 2345-51
|
|
|
|
|
|
44) Keith DS, Demattos A, Golconda M, et al. Effect of donor recipient age match on survival after first deceased donor renal transplantation. J Am Soc Nephrol. 2004; 15: 1086-91
|
|
|
|
|
|
45) Segev DL. Evaluating options for utility-based kidney allocation. Am J Transplant. 2009; 9: 1513-8
|
|
|
|
|